Donna McLaren

VP, Platform Development @Touchlight

London, GB
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Mar 2025 — Present

VP, Platform Development @Touchlight

View department →

London, GB

At Touchlight, we are disrupting the decades-old technology of DNA manufacture to advance genetic medicine. We have developed a novel, synthetic DNA vector, known as doggybone DNA or dbDNA™ and enzymatic manufacturing process, which enables us to produce DNA at unprecedented speed, scale and purity.

EDUCATION

1987 — 1990

University of Liverpool

BSc, Medical Cell Biology

1991 — 1997

University of Cincinnati College of Medicine

MSc, Cell Biology

ABOUT DONNA MCLAREN

An accomplished and visionary leader with a proven track record developing and commercializing innovative cell & gene therapy products; led the CMC activities to commercialize the first lentiviral vector (LVV)-based gene therapy approved for the treatment of metachromatic leukodystrophy (MLD). Functional leadership experience within Technical Operations includes Cell Therapy Operations, CMC Project & Lifecycle Management, and Global Technical Development comprising: Process Development, Analytical Development, and Manufacturing, Science & Technology (MSAT). Has a mission to facilitate the delivery of innovative therapies to patients in need; brings the playbook to develop people, processes, products, and teams to effectively achieve this objective. A highly motivated and team-oriented professional who thrives on finding innovative and creative solutions to overcome challenges. Has a customer-focused approach to business, so is instinctively driven to achieve the best outcome for all stakeholders while maximizing on opportunities to deliver operational efficiencies.Specialties: cell and gene therapy autologous therapies, allogeneic cell therapies, process development, commercialization (experiences with EMA & FDA regulatory filings), lifecycle management, specialized supply chain for autologous products, stem cells for drug discovery, cell-based assay development, automation of scaled-up stem cell culture, people development.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Donna McLaren — VP, Platform Development at Touchlight in London, GB | Unifers